158 related articles for article (PubMed ID: 32537008)
1. Expression of eukaryotic translation initiation factor 3 subunit B in liver cancer and its prognostic significance.
Yue Q; Meng L; Jia B; Han W
Exp Ther Med; 2020 Jul; 20(1):436-446. PubMed ID: 32537008
[TBL] [Abstract][Full Text] [Related]
2. Eukaryotic translation initiation factor 3 subunit B could serve as a potential prognostic predictor for breast cancer.
Song S; Liu J; Zhang M; Gao X; Sun W; Liu P; Wang Y; Li J
Bioengineered; 2022 Feb; 13(2):2762-2776. PubMed ID: 35040374
[TBL] [Abstract][Full Text] [Related]
3. The expression of eukaryotic translation initiation factor 3B and its correlation with tumor characteristics as well as prognosis in non-small cell lung cancer patients: a retrospective study.
Liu C; Li X; Tian J; Zhang S; Liu Y; Zhai X; Feng Q
J BUON; 2020; 25(5):2350-2357. PubMed ID: 33277855
[TBL] [Abstract][Full Text] [Related]
4. Eukaryotic translation initiation factor 3B is overexpressed and correlates with deteriorated tumor features and unfavorable survival profiles in cervical cancer patients.
Zhu P; Tan Q; Jiang W; Ou Y; Xu P; Yuan L
Cancer Biomark; 2019; 26(2):123-130. PubMed ID: 31322539
[TBL] [Abstract][Full Text] [Related]
5. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.
Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D
Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324
[TBL] [Abstract][Full Text] [Related]
6. Eukaryotic translation initiation factor 3 subunit B promotes head and neck cancer via CEBPB translation.
Xu C; Shen Y; Shi Y; Zhang M; Zhou L
Cancer Cell Int; 2022 Apr; 22(1):161. PubMed ID: 35459206
[TBL] [Abstract][Full Text] [Related]
7. EIF3B is associated with poor outcomes in gastric cancer patients and promotes cancer progression via the PI3K/AKT/mTOR signaling pathway.
Wang L; Wen X; Luan F; Fu T; Gao C; Du H; Guo T; Han J; Huangfu L; Cheng X; Ji J
Cancer Manag Res; 2019; 11():7877-7891. PubMed ID: 31686906
[TBL] [Abstract][Full Text] [Related]
8. Expression of La Ribonucleoprotein Domain Family Member 4B (LARP4B) in Liver Cancer and Their Clinical and Prognostic Significance.
Li Y; Jiao Y; Li Y; Liu Y
Dis Markers; 2019; 2019():1569049. PubMed ID: 31772683
[TBL] [Abstract][Full Text] [Related]
9. EIF3B Associates with Exacerbated Clinical Features, Poor Treatment Response and Survival in Adult Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Patients.
Zhu F; Fu Y; He X
Technol Cancer Res Treat; 2021; 20():15330338211041464. PubMed ID: 34617851
[No Abstract] [Full Text] [Related]
10. Eukaryotic initiation factor 3B is overexpressed and correlates with larger tumor size, advanced FIGO stage, and shorter overall survival in epithelial ovarian cancer patients.
Zhao N; Guo Y; He Y; Chen Y; Xing J
J Clin Lab Anal; 2020 Aug; 34(8):e23354. PubMed ID: 32419232
[TBL] [Abstract][Full Text] [Related]
11. Establishing a Prognostic Model Based on Ulceration and Immune Related Genes in Melanoma Patients and Identification of EIF3B as a Therapeutic Target.
Wu Z; Lei K; Xu S; He J; Shi E
Front Immunol; 2022; 13():824946. PubMed ID: 35273605
[TBL] [Abstract][Full Text] [Related]
12. Eukaryotic Translation Initiation Factor 3b is both a Promising Prognostic Biomarker and a Potential Therapeutic Target for Patients with Clear Cell Renal Cell Carcinoma.
Zang Y; Zhang X; Yan L; Gu G; Li D; Zhang Y; Fang L; Fu S; Ren J; Xu Z
J Cancer; 2017; 8(15):3049-3061. PubMed ID: 28928896
[TBL] [Abstract][Full Text] [Related]
13. Eukaryotic translation initiation factor 3 subunit b is a novel oncogenic factor in prostate cancer.
Xiang P; Sun Y; Fang Z; Yan K; Fan Y
Mamm Genome; 2020 Aug; 31(7-8):197-204. PubMed ID: 32556998
[TBL] [Abstract][Full Text] [Related]
14. High EIF2B5 mRNA expression and its prognostic significance in liver cancer: a study based on the TCGA and GEO database.
Jiao Y; Fu Z; Li Y; Meng L; Liu Y
Cancer Manag Res; 2018; 10():6003-6014. PubMed ID: 30538549
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of SKA3 correlates with poor prognosis in female early breast cancer.
Zhong Y; Zhuang Z; Mo P; Lin M; Gong J; Huang J; Mo H; Lu Y; Huang M
PeerJ; 2021; 9():e12506. PubMed ID: 34993016
[TBL] [Abstract][Full Text] [Related]
16. Aberrant FAM64A mRNA expression is an independent predictor of poor survival in pancreatic cancer.
Jiao Y; Fu Z; Li Y; Zhang W; Liu Y
PLoS One; 2019; 14(1):e0211291. PubMed ID: 30695070
[TBL] [Abstract][Full Text] [Related]
17. Translation initiation factor eIF3b expression in human cancer and its role in tumor growth and lung colonization.
Wang H; Ru Y; Sanchez-Carbayo M; Wang X; Kieft JS; Theodorescu D
Clin Cancer Res; 2013 Jun; 19(11):2850-60. PubMed ID: 23575475
[TBL] [Abstract][Full Text] [Related]
18. Eukaryotic initiation factor 3b regulates the development and progression of breast cancer.
Li Y; Zhao J; Yuan Z; Yuan D; Fang M; Xie M; Xia M
Am J Cancer Res; 2023; 13(5):2188-2200. PubMed ID: 37293180
[TBL] [Abstract][Full Text] [Related]
19. HN1 as a diagnostic and prognostic biomarker for liver cancer.
Liu Z; Yang D; Li Y; Jiao Y; Lv G
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32700728
[TBL] [Abstract][Full Text] [Related]
20. Eukaryotic Translation Initiation Factor 3 Subunit B Is a Promoter in the Development and Progression of Pancreatic Cancer.
Ren H; Mai G; Liu Y; Xiang R; Yang C; Su W
Front Oncol; 2021; 11():644156. PubMed ID: 33996561
[No Abstract] [Full Text] [Related]
[Next] [New Search]
